WELCOME TO THE UK SITE FOR HEMGENIX®▼

(etranacogene dezaparvovec) 

Please choose the category that describes you

I am a member of the public in the UK

Visit site

I am a patient or a carer of a patient prescribed HEMGENIX® in the UK

Visit site

I am a healthcare professional in the UK

Visit site

This medicinal product has been authorised under the conditional approval scheme. This means that further evidence on this medicinal product is awaited.

Reporting side effects
If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme. By reporting side effects, you can help provide more information on the safety of this medicine. Adverse events should also be reported to CSL Behring UK Ltd on 01444 447 405 or at medinfo@cslbehring.com.
 

▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See above for how to report side effects.